ID   KPCE_RAT                Reviewed;         737 AA.
AC   P09216;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-OCT-2024, entry version 204.
DE   RecName: Full=Protein kinase C epsilon type;
DE            EC=2.7.11.13 {ECO:0000250|UniProtKB:Q02156};
DE   AltName: Full=nPKC-epsilon;
GN   Name=Prkce; Synonyms=Pkce;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2834397; DOI=10.1016/s0021-9258(18)68732-0;
RA   Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y.;
RT   "The structure, expression, and properties of additional members of the
RT   protein kinase C family.";
RL   J. Biol. Chem. 263:6927-6932(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 135-297.
RX   PubMed=3691811; DOI=10.1016/0014-5793(87)80564-1;
RA   Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y.;
RT   "Identification of three additional members of rat protein kinase C family:
RT   delta-, epsilon- and zeta-subspecies.";
RL   FEBS Lett. 226:125-128(1987).
RN   [3]
RP   INTERACTION WITH COPB1, AND SUBCELLULAR LOCATION.
RX   PubMed=9360998; DOI=10.1074/jbc.272.46.29200;
RA   Csukai M., Chen C.-H., de Matteis M.A., Mochly-Rosen D.;
RT   "The coatomer protein beta'-COP, a selective binding protein (RACK) for
RT   protein kinase Cepsilon.";
RL   J. Biol. Chem. 272:29200-29206(1997).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF AKT1.
RX   PubMed=11278835; DOI=10.1074/jbc.m011093200;
RA   Matsumoto M., Ogawa W., Hino Y., Furukawa K., Ono Y., Takahashi M.,
RA   Ohba M., Kuroki T., Kasuga M.;
RT   "Inhibition of insulin-induced activation of Akt by a kinase-deficient
RT   mutant of the epsilon isozyme of protein kinase C.";
RL   J. Biol. Chem. 276:14400-14406(2001).
RN   [5]
RP   INTERACTION WITH RACK1 AND TRIM63.
RX   PubMed=15596539; DOI=10.1083/jcb.200402033;
RA   Arya R., Kedar V., Hwang J.R., McDonough H., Li H.-H., Taylor J.,
RA   Patterson C.;
RT   "Muscle ring finger protein-1 inhibits PKC-epsilon activation and prevents
RT   cardiomyocyte hypertrophy.";
RL   J. Cell Biol. 167:1147-1159(2004).
RN   [6]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH PDLIM5 AND N-TYPE CALCIUM
RP   CHANNEL.
RX   PubMed=12665800; DOI=10.1038/nn1041;
RA   Maeno-Hikichi Y., Chang S., Matsumura K., Lai M., Lin H., Nakagawa N.,
RA   Kuroda S., Zhang J.F.;
RT   "A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+
RT   channels.";
RL   Nat. Neurosci. 6:468-475(2003).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF MARCKS.
RX   PubMed=17157309; DOI=10.1016/j.yjmcc.2006.10.017;
RA   Heidkamp M.C., Iyengar R., Szotek E.L., Cribbs L.L., Samarel A.M.;
RT   "Protein kinase Cepsilon-dependent MARCKS phosphorylation in neonatal and
RT   adult rat ventricular myocytes.";
RL   J. Mol. Cell. Cardiol. 42:422-431(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329; SER-337; SER-346;
RP   SER-368; SER-388; THR-710 AND SER-729, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-136.
RX   PubMed=11518534; DOI=10.1006/jmbi.2001.4910;
RA   Ochoa W.F., Garcia-Garcia J., Fita I., Corbalan-Garcia S., Verdaguer N.,
RA   Gomez-Fernandez J.C.;
RT   "Structure of the C2 domain from novel protein kinase Cepsilon. A membrane
RT   binding model for Ca(2+)-independent C2 domains.";
RL   J. Mol. Biol. 311:837-849(2001).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that plays essential roles in
CC       the regulation of multiple cellular processes linked to cytoskeletal
CC       proteins, such as cell adhesion, motility, migration and cell cycle,
CC       functions in neuron growth and ion channel regulation, and is involved
CC       in immune response, cancer cell invasion and regulation of apoptosis.
CC       Mediates cell adhesion to the extracellular matrix via integrin-
CC       dependent signaling, by mediating angiotensin-2-induced activation of
CC       integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS,
CC       which phosphorylates and activates PTK2/FAK, leading to the spread of
CC       cardiomyocytes. Involved in the control of the directional transport of
CC       ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an
CC       intermediate filament (IF) protein. In epithelial cells, associates
CC       with and phosphorylates keratin-8 (KRT8), which induces targeting of
CC       desmoplakin at desmosomes and regulates cell-cell contact.
CC       Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-
CC       cell detachment prior to migration. During cytokinesis, forms a complex
CC       with YWHAB, which is crucial for daughter cell separation, and
CC       facilitates abscission by a mechanism which may implicate the
CC       regulation of RHOA. In cardiac myocytes, regulates myofilament function
CC       and excitation coupling at the Z-lines, where it is indirectly
CC       associated with F-actin via interaction with COPB1. During endothelin-
CC       induced cardiomyocyte hypertrophy, mediates activation of PTK2/FAK,
CC       which is critical for cardiomyocyte survival and regulation of
CC       sarcomere length. Plays a role in the pathogenesis of dilated
CC       cardiomyopathy via persistent phosphorylation of troponin I (TNNI3).
CC       Involved in nerve growth factor (NFG)-induced neurite outgrowth and
CC       neuron morphological change independently of its kinase activity, by
CC       inhibition of RHOA pathway, activation of CDC42 and cytoskeletal
CC       rearrangement. May be involved in presynaptic facilitation by mediating
CC       phorbol ester-induced synaptic potentiation. Phosphorylates gamma-
CC       aminobutyric acid receptor subunit gamma-2 (GABRG2), which reduces the
CC       response of GABA receptors to ethanol and benzodiazepines and may
CC       mediate acute tolerance to the intoxicating effects of ethanol. Upon
CC       PMA treatment, phosphorylates the capsaicin- and heat-activated cation
CC       channel TRPV1, which is required for bradykinin-induced sensitization
CC       of the heat response in nociceptive neurons. Is able to form a complex
CC       with PDLIM5 and N-type calcium channel, and may enhance channel
CC       activities and potentiates fast synaptic transmission by
CC       phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2).
CC       Downstream of TLR4, plays an important role in the lipopolysaccharide
CC       (LPS)-induced immune response by phosphorylating and activating
CC       TICAM2/TRAM, which in turn activates the transcription factor IRF3 and
CC       subsequent cytokines production. In differentiating erythroid
CC       progenitors, is regulated by EPO and controls the protection against
CC       the TNFSF10/TRAIL-mediated apoptosis, via BCL2. May be involved in the
CC       regulation of the insulin-induced phosphorylation and activation of
CC       AKT1. Phosphorylates NLRP5/MATER and may thereby modulate AKT pathway
CC       activation in cumulus cells (By similarity). Phosphorylates and
CC       activates LRRK1, which phosphorylates RAB proteins involved in
CC       intracellular trafficking (By similarity).
CC       {ECO:0000250|UniProtKB:Q02156, ECO:0000269|PubMed:11278835,
CC       ECO:0000269|PubMed:12665800, ECO:0000269|PubMed:17157309}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC         Evidence={ECO:0000250|UniProtKB:Q02156};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13; Evidence={ECO:0000250|UniProtKB:Q02156};
CC   -!- ACTIVITY REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-566 (activation loop of
CC       the kinase domain), Thr-710 (turn motif) and Ser-729 (hydrophobic
CC       region), need to be phosphorylated for its full activation.
CC   -!- SUBUNIT: Forms a ternary complex with TRIM63 and RACK1/GN2BL1
CC       (PubMed:15596539). Can form a complex with PDLIM5 and N-type calcium
CC       channel (PubMed:12665800). Interacts with COPB1 (PubMed:9360998).
CC       Interacts with DGKQ (By similarity). Interacts with STAT3 (By
CC       similarity). Interacts with YWHAB (By similarity). Interacts with
CC       HSP90AB1; promotes functional activation in a heat shock-dependent
CC       manner (By similarity). Interacts (via phorbol-ester/DAG-type 2 domain)
CC       with PRPH and VIM (By similarity). Interacts with NLRP5/MATER (By
CC       similarity). {ECO:0000250|UniProtKB:P16054,
CC       ECO:0000250|UniProtKB:Q02156, ECO:0000269|PubMed:12665800,
CC       ECO:0000269|PubMed:15596539, ECO:0000269|PubMed:9360998}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q02156}.
CC       Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q02156}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q02156}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:9360998}. Nucleus {ECO:0000250|UniProtKB:P16054}.
CC       Note=Translocated to plasma membrane in epithelial cells stimulated by
CC       HGF (By similarity). Associated with the Golgi at the perinuclear site
CC       in pre-passage fibroblasts (By similarity). In passaging cells,
CC       translocated to the cell periphery (By similarity). Translocated to the
CC       nucleus in PMA-treated cells (By similarity).
CC       {ECO:0000250|UniProtKB:P16054, ECO:0000250|UniProtKB:Q02156}.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type region 1
CC       (C1A) and 2 (C1B), is the diacylglycerol sensor and the C2 domain is a
CC       non-calcium binding domain.
CC   -!- PTM: Phosphorylation on Thr-566 by PDPK1 triggers autophosphorylation
CC       on Ser-729. Phosphorylation in the hinge domain at Ser-350 by MAPK11 or
CC       MAPK14, Ser-346 by GSK3B and Ser-368 by autophosphorylation is required
CC       for interaction with YWHAB (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18331; AAA41872.1; -; mRNA.
DR   PIR; B28163; KIRTCE.
DR   RefSeq; NP_058867.1; NM_017171.1.
DR   PDB; 1GMI; X-ray; 1.70 A; A=1-136.
DR   PDBsum; 1GMI; -.
DR   AlphaFoldDB; P09216; -.
DR   SMR; P09216; -.
DR   BioGRID; 247999; 7.
DR   CORUM; P09216; -.
DR   IntAct; P09216; 5.
DR   STRING; 10116.ENSRNOP00000020959; -.
DR   BindingDB; P09216; -.
DR   ChEMBL; CHEMBL3424; -.
DR   DrugCentral; P09216; -.
DR   GlyGen; P09216; 12 sites, 1 O-linked glycan (12 sites).
DR   iPTMnet; P09216; -.
DR   PhosphoSitePlus; P09216; -.
DR   SwissPalm; P09216; -.
DR   PaxDb; 10116-ENSRNOP00000020959; -.
DR   GeneID; 29340; -.
DR   KEGG; rno:29340; -.
DR   UCSC; RGD:61925; rat.
DR   AGR; RGD:61925; -.
DR   CTD; 5581; -.
DR   RGD; 61925; Prkce.
DR   eggNOG; KOG0694; Eukaryota.
DR   InParanoid; P09216; -.
DR   OrthoDB; 841660at2759; -.
DR   PhylomeDB; P09216; -.
DR   BRENDA; 2.7.11.13; 5301.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-RNO-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-RNO-1489509; DAG and IP3 signaling.
DR   Reactome; R-RNO-2029485; Role of phospholipids in phagocytosis.
DR   EvolutionaryTrace; P09216; -.
DR   PRO; PR:P09216; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0071944; C:cell periphery; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:SynGO.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISO:RGD.
DR   GO; GO:0003785; F:actin monomer binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0004699; F:diacylglycerol-dependent, calcium-independent serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0008047; F:enzyme activator activity; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0035276; F:ethanol binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; IPI:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:RGD.
DR   GO; GO:0030546; F:signaling receptor activator activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0031589; P:cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISO:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035641; P:locomotory exploration behavior; ISO:RGD.
DR   GO; GO:0002281; P:macrophage activation involved in immune response; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0070254; P:mucus secretion; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0051562; P:negative regulation of mitochondrial calcium ion concentration; IMP:UniProtKB.
DR   GO; GO:0010917; P:negative regulation of mitochondrial membrane potential; IMP:UniProtKB.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0051280; P:negative regulation of release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:2001031; P:positive regulation of cellular glucuronidation; ISO:RGD.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0070257; P:positive regulation of mucus secretion; ISO:RGD.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISO:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISO:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0043278; P:response to morphine; ISO:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0035669; P:TRAM-dependent toll-like receptor 4 signaling pathway; ISS:UniProtKB.
DR   CDD; cd20835; C1_nPKC_epsilon-like_rpt1; 1.
DR   CDD; cd20838; C1_nPKC_epsilon-like_rpt2; 1.
DR   CDD; cd04014; C2_PKC_epsilon; 1.
DR   CDD; cd05591; STKc_nPKC_epsilon; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR034669; nPKC_epsilon.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027274; PKC_epsilon.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24351:SF182; PROTEIN KINASE C EPSILON TYPE; 1.
DR   PANTHER; PTHR24351; RIBOSOMAL PROTEIN S6 KINASE; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501106; Protein_kin_C_epsilon; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell adhesion; Cell cycle; Cell division;
KW   Cell membrane; Cytoplasm; Cytoskeleton; Immunity; Kinase; Membrane;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..737
FT                   /note="Protein kinase C epsilon type"
FT                   /id="PRO_0000055700"
FT   DOMAIN          1..117
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          408..668
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          669..737
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         169..220
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         242..292
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          310..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          369..398
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           223..228
FT                   /note="Interaction with actin"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        330..351
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        532
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         414..422
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         437
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16054"
FT   MOD_RES         228
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02156"
FT   MOD_RES         234
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16054"
FT   MOD_RES         309
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02156"
FT   MOD_RES         316
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02156"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         349
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P16054"
FT   MOD_RES         350
FT                   /note="Phosphoserine; by MAPK11 and MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:P16054"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         566
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q02156"
FT   MOD_RES         703
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         710
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         729
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   STRAND          4..17
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   HELIX           22..25
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          40..46
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          49..53
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          64..76
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          78..85
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          93..101
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   HELIX           102..105
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          111..118
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          120..122
FT                   /evidence="ECO:0007829|PDB:1GMI"
FT   STRAND          124..135
FT                   /evidence="ECO:0007829|PDB:1GMI"
SQ   SEQUENCE   737 AA;  83478 MW;  6AD6999EFDD2659F CRC64;
     MVVFNGLLKI KICEAVSLKP TAWSLRHAVG PRPQTFLLDP YIALNVDDSR IGQTATKQKT
     NSPAWHDEFV TDVCNGRKIE LAVFHDAPIG YDDFVANCTI QFEELLQNGS RHFEDWIDLE
     PEGKVYVIID LSGSSGEAPK DNEERVFRER MRPRKRQGAV RRRVHQVNGH KFMATYLRQP
     TYCSHCRDFI WGVIGKQGYQ CQVCTCVVHK RCHELIITKC AGLKKQETPD EVGSQRFSVN
     MPHKFGIHNY KVPTFCDHCG SLLWGLLRQG LQCKVCKMNV HRRCETNVAP NCGVDARGIA
     KVLADLGVTP DKITNSGQRR KKLAAGAESP QPASGNSPSE DDRSKSAPTS PCDQELKELE
     NNIRKALSFD NRGEEHRASS STDGQLASPG ENGEVRQGQA KRLGLDEFNF IKVLGKGSFG
     KVMLAELKGK DEVYAVKVLK KDVILQDDDV DCTMTEKRIL ALARKHPYLT QLYCCFQTKD
     RLFFVMEYVN GGDLMFQIQR SRKFDEPRSG FYAAEVTSAL MFLHQHGVIY RDLKLDNILL
     DAEGHSKLAD FGMCKEGILN GVTTTTFCGT PDYIAPEILQ ELEYGPSVDW WALGVLMYEM
     MAGQPPFEAD NEDDLFESIL HDDVLYPVWL SKEAVSILKA FMTKNPHKRL GCVAAQNGED
     AIKQHPFFKE IDWVLLEQKK MKPPFKPRIK TKRDVNNFDQ DFTREEPILT LVDEAIVKQI
     NQEEFKGFSY FGEDLMP
//
